Heparin Sodium Injection
Product Images NDC 25021-404

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 25021-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hep01 0015 01

Chemical structure diagram depicting the molecular components of heparin sodium, the active ingredient in Heparin Sodium injection 20000 [USP'U]/mL by Sagent Pharmaceuticals.*

FDA Label Image

Hep01 0015 02

Label for Heparin Sodium Injection, USP 20,000 USP units per mL in a 1 mL multi-dose vial by Sagent Pharmaceuticals. The label indicates the drug is for intravenous or subcutaneous use, derived from porcine intestinal mucosa. The label includes the NDC 25021-404-01 and manufacturing details noting it is made in India for Sagent Pharmaceuticals, Schaumburg, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.